CASI Pharmaceuticals Inc
CASI
Market Cap$30.02M
Close$
$3.55
54.4% upside
Current Fair Value
54.4% upsideUndervalued by 54.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $30.02 Million |
|---|---|
| Enterprise Value | $-18,554,920.00 |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.0 |
| Beta | -0.21 |
| Outstanding Shares | 13,401,375 |
| Avg 30 Day Volume | 63,791 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | 0.0 |
| Price to Sales | 0.77 |
| Price to Book Ratio | 0.77 |
| Enterprise Value to Revenue | -0.43 |
| Enterprise Value to EBIT | 0.73 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About CASI Pharmaceuticals Inc
CEO: Wei-Wu He CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on...